September 7, 2017 09:28 AM EDTUpdated 09:42 AM

Bristol-Myers' checkpoint combo scores in PhIII study; AstraZeneca hands Circassia positive data for COPD drug; Woodford apologizes again

Shehla Shakoor

Managing Director

⇨ Bristol-Myers Squibb did get some good news on the checkpoint front today. The company says that their combination of Opdivo and Yervoy scored …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bristol-Myers' checkpoint combo scores in PhIII study; AstraZeneca hands Circassia positive data for COPD drug; Woodford apologizes again

Shehla Shakoor

Managing Director

Sign up to read this article for free.

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Jazz wins approval for bispecific in biliary tract cancer

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

At Jefferies, all that manufacturers want to talk about is GLP-1s

FDA vaccine chief Peter Marks pledges to stay as long as he's welcome

Are programs with compounded GLP-1s safe for your population?

Bris­tol-My­er­s' check­point com­bo scores in PhI­II study; As­traZeneca hands Cir­cas­sia pos­i­tive da­ta for COPD drug; Wood­ford apol­o­gizes again

Shehla Shakoor

Managing Director

Sign up to read this article for free.

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

Bristol-Myers' checkpoint combo scores in PhIII study; AstraZeneca hands Circassia positive data for COPD drug; Woodford apologizes again

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Jazz wins approval for bispecific in biliary tract cancer

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

At Jefferies, all that manufacturers want to talk about is GLP-1s

FDA vaccine chief Peter Marks pledges to stay as long as he's welcome

Are programs with compounded GLP-1s safe for your population?